2013

• Lee, C., Simes, R., Brown, C., Gebski, V., Pfisterer, J., Swart, A., Berton-Rigaud, D., Plante, M., Skeie-Jensen, T., Vergote, I., Schauer, C., Pisano, C., Parma, G., Baumann, K., Ledermann, J., Pujade-Lauraine, E., Bentley, J., Kristensen, G., Belau, A., Nankivell, M., Canzler, U., Lord, S., Kurzeder, C., Friedlander, M. (2013), A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer. Annals of Oncology. 24(4), 937-943. [Abstract]

2012

• Lew, J., Howard, K., Gertig, D., Smith, M., Clements, M., Nickson, C., Shi, J., Dyer, S., Lord, S., Creighton, P., Kang, Y., Tan, J., Canfell, K. (2012), Expenditure and resource utilisation for cervical screening in Australia. BMC Health Services Research. 12(1), 446. [Abstract]
• Lord, S., Marinovich, M., Patterson, J., Wilcken, N., Kiely, B., Gebski, V., Crossing, S., Roder, D., Gattellari, M., Houssami, N. (2012), Incidence of metastatic breast cancer in an Australian population-based cohort of women with non-metastatic breast cancer at diagnosis. Medical Journal of Australia. 196(11), 688-692. [Abstract]
• Walter, S., Macaskill, P., Lord, S., Irwig, L. (2012), Effect of dependent errors in the assessment of diagnostic or screening test accuracy when the reference standard is imperfect. Statistics in Medicine. 31(11-12), 1129-1138. [Abstract]
• Verry, H., Lord, S., Martin, A., Gill, G., Lee, C., Howard, K., Wetzig, N., Simes, J. (2012), Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis. British Journal of Cancer. 106(6), 1045-1052. [Abstract]
• Staub, L., Dyer, S., Lord, S., Simes, R. (2012), Linking the evidence: intermediate outcomes in medical test assessments. International Journal of Technology Assessment in Health Care. 28(1), 52-58. [Abstract]
• Staub, L., Lord, S., Simes, R., Dyer, S., Houssami, N., Chen, R., Irwig, L. (2012), Using patient management as a surrogate for patient health outcomes in diagnostic test evaluation. BMC Medical Research Methodology. 12, 12. [Abstract]

2011

• Lee, C., Simes, R., Brown, C., Lord, S., Wagner, U., Plante, M., Vergote, I., Pisano, C., Parma, G., Burges, A., Bourgeois, H., Högberg, T., Bentley, J., Angleitner-Boubenizek, L., Ferrero, A., Richter, B., Hirte, H., Gebski, V., Pfisterer, J., Pujade-Lauraine, E., Friedlander, M. (2011), Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer. British journal of cancer. 105(8), 1144-50. [Abstract]
• Lee, C., Friedlander, M., Brown, C., Gebski, V., Georgoulopoulos, A., Vergote, I., Pignata, S., Donadello, N., Schmalfeldt, B., Delva, R., Mirza, M., Sauthier, P., Pujade-Lauraine, E., Lord, S., Simes, R. (2011), Early Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian Cancer. Journal of the National Cancer Institute. 103(17), 1338-42. [Abstract]
• Lee, C., Hudson, M., Stockler, M., Coates, A., Ackland, S., Gebski, V., Lord, S., Friedlander, M., Boyle, F., Simes, R. (2011), A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancer. Breast cancer research and treatment. 129(2), 467-76. [Abstract]
• Lee, C., Gurney, H., Brown, C., Sorio, R., Donadello, N., Tulunay, G., Meier, W., Bacon, M., Maenpaa, J., Petru, E., Reed, N., Gebski, V., Pujade-Lauraine, E., Lord, S., Simes, R., Friedlander, M. (2011), Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer. British journal of cancer. 105(3), 360-5. [Abstract]
• Staub, L., Barz, T., Melloh, M., Lord, S., Chatfield, M., Bossuyt, P. (2011), Clinical validation study to measure the performance of the Nerve Root Sedimentation Sign for the diagnosis of lumbar spinal stenosis. Contemporary Clinical Trials. 32(3), 470-474. [Abstract]
• Lord, S., Staub, L., Bossuyt, P., Irwig, L. (2011), Target practice: choosing target conditions for test accuracy studies that are relevant to clinical practice. BMJ. 343, d4684. [Abstract]

2010

• Barz, T., Staub, L., Melloh, M., Lord, S. (2010), Letters. Spine. 35(24), E1360. [Abstract]
• Botelho, N., Schneiders, F., Lord, S., Freeman, A., Tyagi, S., Nancarrow, D., Hayward, N., Whiteman, D., Lord, R. (2010), Gene expression alterations in formalin-fixed, paraffin-embedded Barrett's esophagus and esophageal adenocarcinoma tissues. Cancer biology & therapy. 10(2), 172-9. [Abstract]
• Lee, C., Stockler, M., Coates, A., Gebski, V., Lord, S., Simes, R. (2010), Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer. British journal of cancer. 102(9), 1341-7. [Abstract]
• Barz, T., Melloh, M., Staub, L., Lord, S., Lange, J., Röder, C., Theis, J., Merk, H. (2010), Nerve Root Sedimentation Sign: Evaluation of a New Radiological Sign in Lumbar Spinal Stenosis. Spine. 35(8), 892-7. [Abstract]
• Griffiths, A., Dyer, S., Lord, S., Pardy, C., Fraser, I., Eckermann, S. (2010), A cost-effectiveness analysis of in-vitro fertilization by maternal age and number of treatment attempts. Human Reproduction. 25(4), 924-931. [Abstract]
• Lee, C., Lord, S., Stockler, M., Coates, A., Gebski, V., Simes, R. (2010), Historical cross-trial comparisons for competing treatments in advanced breast cancer - An empirical analysis of bias. European journal of cancer (Oxford, England : 1990). 46(3), 541-8. [Abstract]
• Creighton, P., Lew, J., Clements, M., Smith, M., Howard, K., Dyer, S., Lord, S., Canfell, K. (2010), Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years. BMC public health. 10(1), 734. [Abstract]

2009

• Brennan, M., Houssami, N., Lord, S., Macaskill, P., Irwig, L., Dixon, J., Warren, R., Ciatto, S. (2009), Magnetic Resonance Imaging Screening of the Contralateral Breast in Women With Newly Diagnosed Breast Cancer: Systematic Review and Meta-Analysis of Incremental Cancer Detection and Impact on Surgical Management. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(33), 5640-9. [Abstract]
• Lee, C., Lord, S., Coates, A., Simes, R. (2009), Molecular biomarkers to individualise treatment: assessing the evidence. The Medical Journal of Australia. 190(11), 631-636. [Abstract]
• Houssami, N., Lord, S., Ciatto, S. (2009), Breast cancer screening: emerging role of new imaging techniques as adjuncts to mammography. The Medical Journal of Australia. 190(9), 493-497. [Abstract]
• Urwyler, N., Staub, L., Beran, D., Deplazes, M., Lord, S., Alberio, L., Theiler, L., Greif, R. (2009), Is perioperative point-of-care prothrombin time testing accurate compared to the standard laboratory test?. Thrombosis and Haemostasis. 102(4), 779-786. [Abstract]
• Lord, S., Irwig, L., Bossuyt, P. (2009), Using the principles of randomized controlled trial design to guide test evaluation. Medical Decision Making. 29(5), E1-E12. [Abstract]

2008

• Houssami, N., Ciatto, S., Macaskill, P., Lord, S., Warren, R., Dixon, J., Irwig, L. (2008), Accuracy and Surgical Impact of Magnetic Resonance Imaging in Breast Cancer Staging: Systematic Review and Meta-Analysis in Detection of Multifocal and Multicentric Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(19), 3248-58. [Abstract]
• Lord, S., Bernstein, L., Johnson, K., Malone, K., McDonald, J., Marchbanks, P., Simon, M., Strom, B., Press, M., Folger, S., Burkman, R., Deapen, D., Spirtas, R., Ursin, G. (2008), Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control study. Cancer Epidemiology, Biomarkers & Prevention. 17(7), 1723-1730. [Abstract]
• Dyer, S., Levison, D., Chen, R., Lord, S., Blamey, S. (2008), Systematic review of the impact of endoscopic ultrasound on the management of patients with esophageal cancer. International Journal of Technology Assessment in Health Care. 24(1), 25-35. [Abstract]

2007

• Walleser, S., Griffiths, A., Lord, S., Howard, K., Solomon, M., Gebski, V. (2007), What is the value of computered tomography colonography in patients screening positive for fecal occult blood? A systematic review and economic evaluation. Clinical Gastroenterology and Hepatology. 5(12), 1439-1446. [Abstract]
• Lord, S., Lei, W., Craft, P., Cawson, J., Morris, I., Walleser, S., Griffiths, A., Parker, S., Houssami, N. (2007), A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. European journal of cancer (Oxford, England : 1990). 43(13), 1905-17. [Abstract]
• Lord, S., Irwig, L., Simes, J. (2007), A philosophical approach to diagnostic test evaluation: author's reply. Annals of Internal Medicine. , 757-759.
• Lord, S., Gebski, V., Keech, A. (2007), Multiple analyses in clinical trials: sound science or data dredging?. In: Interpreting and reporting clinical trials: A guide to the CONSORT statement and the principles of randomised controlled trials. (pp.123-131).Australia: Australasian Medical Publishing Company Ltd..
• Griffiths, A., Marinovich, L., Barton, M., Lord, S. (2007), Cost analysis of Gamma Knife stereotactic radiosurgery. International journal of technology assessment in health care. 23(4), 488-494. [Abstract]